Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Plummer

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
BMJ Medicine|February 27, 2026
Making clinical guidelines work for people with multiple long term conditions: analysis and recommendations from review of single condition guidelinesSara Pretorius, Victoria Bartle, Sue Bellass, et al.
European Journal of Heart Failure|February 20, 2018
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?Kenneth Dickstein, Camilla Normand, Angelo Auricchio, et al.
Health Technology Assessment (Winchester, England)|September 4, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCTHelena Earl, Louise Hiller, Anne-Laure Vallier, et al.
European Heart Journal. Digital Health|September 25, 2024
Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee: Developed in collaboration with the European Heart Rhythm Association (EHRA), the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC, the Heart Failure Association (HFA) of the ESC, the ESC Young Community, the ESC Working Group on e-Cardiology, the ESC Council for Cardiology Practice, the ESC Council of Cardio-Oncology, the ESC Council on Hypertension, the ESC Patient Forum, the ESC Digital Health Committee, and the European Association of Preventive Cardiology (EAPC)Enrico G Caiani, Hareld Kemps, Petra Hoogendoorn, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2021
Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupElvira C van Dalen, Renée L Mulder, Eugene Suh, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 4, 2026
Clinical Practice Guideline Implementation: Challenges and Solutions for Improved Cardiovascular CareEva Prescott, Suleman Aktaa, Amr Abdin, et al.
Journal of Multimorbidity and Comorbidity|February 3, 2025
Building ADMISSION - A research collaborative to transform understanding of multiple long-term conditions for people admitted to hospitalMiles D Witham, Victoria Bartle, Sue Bellass, et al.
Lancet (London, England)|June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialHelena M Earl, Louise Hiller, Anne-Laure Vallier, et al.
JACC. Cardiooncology|October 31, 2024
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical TrialDavid Austin, Rebecca H Maier, Nasima Akhter, et al.
European Journal of Heart Failure|December 7, 2023
European Society of Cardiology Core Curriculum for cardio-oncologyTeresa López-Fernández, Dimitrios Farmakis, Pietro Ameri, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
BMJ Medicine|February 27, 2026
Making clinical guidelines work for people with multiple long term conditions: analysis and recommendations from review of single condition guidelinesSara Pretorius, Victoria Bartle, Sue Bellass, et al.
European Journal of Heart Failure|February 20, 2018
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?Kenneth Dickstein, Camilla Normand, Angelo Auricchio, et al.
Health Technology Assessment (Winchester, England)|September 4, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCTHelena Earl, Louise Hiller, Anne-Laure Vallier, et al.
European Heart Journal. Digital Health|September 25, 2024
Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee: Developed in collaboration with the European Heart Rhythm Association (EHRA), the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC, the Heart Failure Association (HFA) of the ESC, the ESC Young Community, the ESC Working Group on e-Cardiology, the ESC Council for Cardiology Practice, the ESC Council of Cardio-Oncology, the ESC Council on Hypertension, the ESC Patient Forum, the ESC Digital Health Committee, and the European Association of Preventive Cardiology (EAPC)Enrico G Caiani, Hareld Kemps, Petra Hoogendoorn, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2021
Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupElvira C van Dalen, Renée L Mulder, Eugene Suh, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 4, 2026
Clinical Practice Guideline Implementation: Challenges and Solutions for Improved Cardiovascular CareEva Prescott, Suleman Aktaa, Amr Abdin, et al.
Journal of Multimorbidity and Comorbidity|February 3, 2025
Building ADMISSION - A research collaborative to transform understanding of multiple long-term conditions for people admitted to hospitalMiles D Witham, Victoria Bartle, Sue Bellass, et al.
Lancet (London, England)|June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trialHelena M Earl, Louise Hiller, Anne-Laure Vallier, et al.
JACC. Cardiooncology|October 31, 2024
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical TrialDavid Austin, Rebecca H Maier, Nasima Akhter, et al.
European Journal of Heart Failure|December 7, 2023
European Society of Cardiology Core Curriculum for cardio-oncologyTeresa López-Fernández, Dimitrios Farmakis, Pietro Ameri, et al.
Pageof 8